PerkinElmer Elects Patrick J. Sullivan as Director
Sullivan brings extensive management experience in the diagnostic and medical device industries to his role with PerkinElmer. Prior to his appointment as Chairman of Hologic, which occurred with the merger of Cytyc Corporation with Hologic, Inc. in October of 2007, he served as Chairman, President and CEO of Cytyc Corporation. Previously, Sullivan held sales and marketing leadership roles with Abbott Laboratories, where he played a key role in driving the growth of its Physician Office Diagnostics business. Sullivan also worked as a consultant with McKinsey & Company.
Sullivan holds an M.B.A., with distinction, from Harvard University and a B.S., with distinction, from the United States Naval Academy.
Most read news
Topics
Organizations
Other news from the department people
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.